Stocks›Healthcare›TEVA

TEVA

Teva Pharmaceutical Industries Limited

NYSEResearch view

Teva Pharmaceutical Industries Limited operates in the Pharmaceutical Preparations industry.

$39.66+0.33%

Oct 5 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsLarge-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 6, 2024, before the open.

Last report

Jul 29, 2026+9.60%

before the open

Last 4, next close

median 10.75% either way

up 4 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Jul 29Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+9.60%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

27 big days in a year, and what we hold on each

A big day is a close more than 3.36% from the one before, three times TEVA’s median day (1.12%). On 5 of the 27, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.36%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayTEVAWhat we hold that dayGroup (median of 4) · each

1 Oct 27, 2025+3.48%
Before our storiesgroup +0.1%, did not move with it
1Oct 27, 2025+3.48%
Before our stories
+0.1% did not move with itMRK +0.6 · LLY +0.1 · ABBV +0.0 · JNJ −0.1
2 Nov 5, 2025+20.23%
Resultsgroup +0.5%, did not move with it
2Nov 5, 2025+20.23%
ResultsFirst close after the Nov 5 results filing
+0.5% did not move with itLLY +2.1 · MRK +0.6 · ABBV +0.4 · JNJ −0.5
3 Nov 11, 2025+3.59%
Before our storiesgroup +2.9%, moved with TEVA
3Nov 11, 2025+3.59%
Before our stories
+2.9% moved with TEVAMRK +4.8 · ABBV +3.0 · JNJ +2.9 · LLY +2.3
4 Nov 26, 2025+5.32%
Before our storiesgroup −0.7%, did not move with it
4Nov 26, 2025+5.32%
Before our stories
−0.7% did not move with itJNJ +0.4 · LLY −0.5 · MRK −1.0 · ABBV −1.8
5 Dec 3, 2025+3.53%
Before our storiesgroup +0.6%, did not move with it
5Dec 3, 2025+3.53%
Before our stories
+0.6% did not move with itABBV +2.6 · MRK +1.2 · JNJ −0.0 · LLY −1.2
6 Dec 10, 2025+4.34%
Before our storiesgroup +1.1%, did not move with it
6Dec 10, 2025+4.34%
Before our stories
+1.1% did not move with itJNJ +3.3 · LLY +1.2 · ABBV +1.0 · MRK +0.8
7 Jan 6, 2026+3.58%
Before our storiesgroup +1.5%, did not move with it
7Jan 6, 2026+3.58%
Before our stories
+1.5% did not move with itLLY +2.2 · ABBV +1.7 · MRK +1.3 · JNJ +0.2
8 Feb 2, 2026+4.23%
Before our storiesgroup +1.4%, did not move with it
8Feb 2, 2026+4.23%
Before our stories
+1.4% did not move with itMRK +2.8 · JNJ +1.5 · ABBV +1.2 · LLY +0.7
9 Feb 4, 2026−3.56%
Before our storiesgroup +1.4%, did not move with it
9Feb 4, 2026−3.56%
Before our stories
+1.4% did not move with itABBV −3.8 · JNJ +0.6 · MRK +2.1 · LLY +10.3
10 Mar 3, 2026−4.41%
Before our storiesgroup −0.9%, did not move with it
10Mar 3, 2026−4.41%
Before our stories
−0.9% did not move with itMRK −1.3 · LLY −1.0 · JNJ −0.7 · ABBV −0.2
11 Mar 5, 2026−3.52%
Before our storiesgroup −2.2%, moved with TEVA
11Mar 5, 2026−3.52%
Before our stories
−2.2% moved with TEVAMRK −3.5 · JNJ −2.3 · LLY −2.0 · ABBV −1.6
12 Mar 12, 2026−3.84%
Before our storiesgroup −0.7%, did not move with it
12Mar 12, 2026−3.84%
Before our stories
−0.7% did not move with itLLY −2.3 · ABBV −1.0 · JNJ −0.4 · MRK −0.3
13 Mar 27, 2026−3.49%
Before our storiesgroup −0.1%, did not move with it
13Mar 27, 2026−3.49%
Before our stories
−0.1% did not move with itLLY −2.1 · ABBV −0.8 · JNJ +0.5 · MRK +0.6
14 Mar 31, 2026+6.24%
Before our storiesgroup +1.9%, did not move with it
14Mar 31, 2026+6.24%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
15 Apr 8, 2026+4.06%
Before our storiesgroup +2.5%, moved with TEVA
15Apr 8, 2026+4.06%
Before our stories
+2.5% moved with TEVAMRK +3.3 · ABBV +2.5 · LLY +2.4 · JNJ +1.2
16 Apr 17, 2026+3.65%
Before our storiesgroup +1.2%, did not move with it
16Apr 17, 2026+3.65%
Before our stories
+1.2% did not move with itMRK +3.1 · LLY +2.5 · JNJ −0.1 · ABBV −0.3
17 Apr 29, 2026+11.89%
Resultsgroup +0.3%, did not move with it
17Apr 29, 2026+11.89%
ResultsFirst close after the Apr 29 results filing
+0.3% did not move with itABBV +3.1 · MRK +0.8 · JNJ −0.2 · LLY −2.6
18 Jun 2, 2026−4.50%
Before our storiesgroup +0.1%, did not move with it
18Jun 2, 2026−4.50%
Before our stories
+0.1% did not move with itLLY −1.7 · JNJ −0.3 · MRK +0.4 · ABBV +1.2
19 Jun 4, 2026+4.87%
Before our storiesgroup +4.0%, moved with TEVA
19Jun 4, 2026+4.87%
Before our stories
+4.0% moved with TEVAMRK +4.8 · LLY +4.3 · ABBV +3.6 · JNJ +2.2
20 Jun 9, 2026+3.58%
Before our storiesgroup +0.6%, did not move with it
20Jun 9, 2026+3.58%
Before our stories
+0.6% did not move with itJNJ +2.1 · ABBV +1.1 · MRK +0.1 · LLY −0.4
21 Jul 2, 2026+3.59%
Nothing on TEVAgroup +3.5%, moved with TEVA
21Jul 2, 2026+3.59%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
+3.5% moved with TEVAABBV +4.0 · JNJ +3.6 · MRK +3.3 · LLY +1.9
22 Jul 8, 2026−4.07%
Nothing on TEVAgroup −1.5%, did not move with it
22Jul 8, 2026−4.07%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
−1.5% did not move with itMRK −2.2 · LLY −1.6 · JNJ −1.4 · ABBV −0.8
23 Jul 22, 2026−3.83%
Nothing on TEVAgroup −0.1%, did not move with it
23Jul 22, 2026−3.83%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
−0.1% did not move with itABBV −1.1 · LLY −1.1 · MRK +1.0 · JNJ +2.0
24 Jul 23, 2026+3.42%
Nothing on TEVAgroup +1.7%, did not move with it
24Jul 23, 2026+3.42%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
+1.7% did not move with itMRK +2.4 · LLY +2.0 · ABBV +1.4 · JNJ +1.4
25 Jul 29, 2026+9.60%
Resultsgroup −0.7%, did not move with it
25Jul 29, 2026+9.60%
ResultsFirst close after the Jul 29 results filing
−0.7% did not move with itABBV +0.0 · JNJ −0.5 · LLY −0.9 · MRK −1.1
26 Sep 2, 2026+3.59%
Nothing on TEVAgroup +0.9%, did not move with it
26Sep 2, 2026+3.59%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
+0.9% did not move with itJNJ +1.5 · MRK +1.2 · ABBV +0.7 · LLY +0.0
27 Sep 14, 2026+4.39%
Nothing on TEVAgroup +1.2%, did not move with it
27Sep 14, 2026+4.39%
Nothing on TEVANo TEVA story, brief or results filing in our record that day
+1.2% did not move with itLLY +2.0 · ABBV +1.8 · MRK +0.6 · JNJ +0.3

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in TEVA’s SEC industry; “moved with TEVA” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). TEVA reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.

Reported Nov 5, 2025

day 1+20.23%day 6+26.25%

Reported Jan 28, 2026

day 1+2.09%day 6+7.47%

Reported Apr 29, 2026

day 1+11.89%day 6+14.93%

Reported Jul 29, 2026

day 1+9.60%day 6+9.63%

Next report: expected late October to early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Jul 29 report: +24.82%. Four reports is a small sample.

Every report since 2023 →

Each line is TEVA’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$46.1B

Revenue$17.3B+4.30%

Net income$1.4B

EPS, diluted$1.21+183.40%

Gross margin51.8%

Operating margin12.5%

Return on equity17.8%

Debt / equity3.87

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$46.1B

Enterprise Value$73.2B

Income$1.4B

Sales$17.3B

Book/sh$6.79

Cash/sh$3.05

Dividend TTM$0.00

Payout1%

Employees—

IPO—

Quick Ratio0.80

Current Ratio1.04

Debt/Eq3.87

EPS (ttm)$1.21

EPS this Y183.4%

EPS past 3/5Y—

Sales past 3/5Y5.0%

EPS Y/Y TTM183.4%

Sales Y/Y TTM4.3%

Shs Outstand1.17B

ROA3.5%

ROE17.8%

ROIC7.1%

Gross Margin51.8%

Oper. Margin12.5%

Profit Margin8.2%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$15.9B

FY21

$14.9B

FY22

$15.8B

FY23

$16.5B

FY24

$17.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$15.9B	$14.9B	$15.8B	$16.5B	$17.3B
Gross Profit	$7.6B	$7.0B	$7.6B	$8.1B	$8.9B
Operating Income	$1.7B	$-2.2B	$433.0M	$-303.0M	$2.2B
Net Income	$417.0M	$-2.4B	$-559.0M	$-1.6B	$1.4B
Diluted EPS	$0.38	$-2.20	$-0.50	$-1.45	$1.21
Operating Cash Flow	$798.0M	$1.6B	$1.4B	$1.2B	$1.6B
Free Cash Flow	$236.0M	$1.0B	—	—	—

Same industry

TEVA against four drug peers, a year at 100

TEVA is up 97.6% in a year. All four did less: Merck (+61.8%), Eli Lilly (+36.1%), Johnson & Johnson (+35.7%) and AbbVie (+12.4%). Weekly closes, Oct 3, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

TEVA +97.6%. Merck +61.8%, Eli Lilly +36.1%, Johnson & Johnson +35.7%, AbbVie +12.4%. Weekly closes, Oct 3, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in TEVA’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.08T JNJ$617.0B ABBV$464.4B MRK$356.0B ABT$168.7B PFE$158.5B VRTX$127.9B BMY$124.9B

Build basket with TEVA Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.